HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John M Maris Selected Research

Residual Neoplasm

10/2019Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
11/2016Neuroblastoma.
9/2013Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
12/2011Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John M Maris Research Topics

Disease

202Neoplasms (Cancer)
04/2024 - 08/2003
197Neuroblastoma
03/2024 - 04/2003
14Leukemia
10/2023 - 06/2008
13Rhabdomyosarcoma
05/2024 - 06/2008
13Ewing Sarcoma (Sarcoma, Ewing)
10/2023 - 06/2008
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2020 - 01/2008
9Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 06/2008
8Neoplasm Metastasis (Metastasis)
01/2023 - 12/2009
7Rhabdoid Tumor (Rhabdoid Tumors)
01/2022 - 05/2008
7Glioblastoma (Glioblastoma Multiforme)
02/2021 - 06/2008
7Sarcoma (Soft Tissue Sarcoma)
01/2019 - 11/2003
6Carcinogenesis
03/2024 - 12/2015
5Brain Neoplasms (Brain Tumor)
01/2022 - 05/2008
5Wilms Tumor (Wilm's Tumor)
01/2020 - 05/2008
5Neutropenia
01/2017 - 06/2004
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2023 - 05/2016
4Hypotension (Low Blood Pressure)
12/2022 - 11/2010
4Hypersensitivity (Allergy)
12/2022 - 09/2010
4Hypoxia (Hypoxemia)
01/2020 - 11/2010
4Residual Neoplasm
10/2019 - 12/2011
4Ganglioneuroblastoma
01/2017 - 07/2008
3Medulloblastoma
01/2023 - 01/2020
3Fever (Fevers)
12/2022 - 01/2017
3Glioma (Gliomas)
01/2022 - 05/2017
3Pain (Aches)
01/2017 - 09/2010
3Thrombocytopenia (Thrombopenia)
01/2017 - 06/2004
3Ganglioneuroma
03/2013 - 07/2008
3Carcinoma (Carcinomatosis)
02/2013 - 11/2003
2Pheochromocytoma
12/2023 - 09/2004
2Inborn Genetic Diseases (Disease, Hereditary)
09/2023 - 02/2023
2Genetic Predisposition to Disease (Genetic Predisposition)
03/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

38N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA
01/2017 - 12/2007
33Proteins (Proteins, Gene)FDA Link
01/2024 - 04/2003
24DNA (Deoxyribonucleic Acid)IBA
09/2023 - 12/2003
213-Iodobenzylguanidine (Iobenguane)IBA
01/2024 - 10/2003
16Phosphotransferases (Kinase)IBA
01/2023 - 11/2005
13Messenger RNA (mRNA)IBA
09/2023 - 04/2003
12RNA (Ribonucleic Acid)IBA
10/2023 - 10/2007
12Irinotecan (Camptosar)FDA LinkGeneric
01/2023 - 03/2009
11dinutuximabIBA
01/2023 - 09/2010
10Chimeric Antigen ReceptorsIBA
05/2024 - 12/2015
10Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2005
10Isotretinoin (Accutane)FDA LinkGeneric
10/2019 - 01/2009
9Oncogene Proteins (Oncogene Protein)IBA
12/2023 - 04/2003
9Temozolomide (Temodar)FDA LinkGeneric
01/2023 - 03/2009
9Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2023 - 09/2010
9LigandsIBA
01/2023 - 12/2009
8Interleukin-2 (IL2)IBA
12/2022 - 09/2010
8Protein Isoforms (Isoforms)IBA
01/2017 - 08/2003
7Anaplastic Lymphoma KinaseIBA
03/2024 - 10/2008
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 02/2013
6Immunoconjugates (Immunoconjugate)IBA
12/2023 - 11/2017
6Vincristine (Oncovin)FDA LinkGeneric
11/2021 - 12/2007
6N-Myc Proto-Oncogene ProteinIBA
01/2021 - 03/2013
6Transcription Factors (Transcription Factor)IBA
01/2021 - 12/2006
5EnzymesIBA
04/2021 - 11/2003
5ChromatinIBA
01/2020 - 01/2019
5MLN 8237IBA
12/2018 - 07/2010
5ABT751IBA
06/2014 - 08/2006
5Sirolimus (Rapamycin)FDA Link
05/2012 - 09/2006
4Adrenergic Agents (Adrenergic Drugs)IBA
03/2024 - 12/2019
4Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2024 - 01/2012
4Membrane Proteins (Integral Membrane Proteins)IBA
12/2023 - 01/2020
4AntigensIBA
12/2023 - 01/2019
4EpitopesIBA
12/2023 - 12/2015
4Peptides (Polypeptides)IBA
12/2023 - 11/2021
4adavosertibIBA
01/2023 - 01/2013
4RadiopharmaceuticalsIBA
11/2022 - 05/2012
4NucleotidesIBA
01/2022 - 01/2018
4CytokinesIBA
01/2022 - 06/2013
4Aurora Kinase AIBA
04/2020 - 11/2011
4CatecholaminesIBA
11/2017 - 09/2004
4Monoclonal AntibodiesIBA
01/2017 - 09/2010
4Antineoplastic Agents (Antineoplastics)IBA
10/2016 - 11/2003
4Angiogenesis InhibitorsIBA
11/2014 - 04/2005
3Small Interfering RNA (siRNA)IBA
12/2023 - 04/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2023 - 01/2018
3CrizotinibIBA
01/2023 - 11/2011
3GlypicansIBA
10/2022 - 01/2021
3Immune Checkpoint InhibitorsIBA
02/2021 - 12/2019
3lorukafusp alfaIBA
10/2019 - 11/2010
3ElementsIBA
01/2018 - 12/2015
3Melphalan (Alkeran)FDA LinkGeneric
01/2016 - 01/2006
3Topotecan (Hycamtin)FDA LinkGeneric
11/2013 - 05/2010
3GSK923295IBA
02/2013 - 04/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2012 - 04/2005
3lestaurtinibIBA
12/2011 - 03/2010
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2011 - 11/2005
3Tyrosine (L-Tyrosine)FDA Link
11/2011 - 11/2005
3OligonucleotidesIBA
06/2006 - 04/2003
2HLA-A*24:02 antigenIBA
11/2023 - 11/2021
2Long Noncoding RNAIBA
10/2023 - 08/2015

Therapy/Procedure

98Therapeutics
05/2024 - 10/2003
25Immunotherapy
12/2023 - 09/2010
23Drug Therapy (Chemotherapy)
01/2023 - 07/2003
7Radiotherapy
01/2017 - 10/2003
6Stem Cell Transplantation
04/2015 - 01/2006
5Chemoradiotherapy
10/2017 - 01/2009
4Induction Chemotherapy
01/2019 - 04/2013
3Duration of Therapy
12/2019 - 07/2010